Discontinuation report KIDROLASE
| Report ID | 108355 |
| Drug Identification Number | 01926438 |
| Brand name | KIDROLASE |
| Common or Proper name | L-asparaginase powder for solution |
| Company Name | JAZZ PHARMACEUTICALS FRANCE SAS |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ASPARAGINASE |
| Strength(s) | 10000UNIT |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAVENOUS |
| Packaging size | 1 vial/pack |
| ATC code | L01XX |
| ATC description | OTHER ANTINEOPLASTIC AGENTS |
| Reason for discontinuation | Manufacturing issues |
| Anticipated discontinuation date | 2020-11-10 |
| Actual discontinuation date | 2021-06-30 |
| Remaining supply date | 2020-02-29 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 84 QUAI CHARLES DE GAULLE CITY ONE LYON, AUVERGNE-RHONE-ALPES FRANCE 69006 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2021-09-01 | French | Compare |
| v5 | 2021-09-01 | English | Compare |
| v4 | 2021-09-01 | English | Compare |
| v3 | 2020-03-10 | French | Compare |
| v2 | 2020-03-10 | English | Compare |
| v1 | 2020-03-10 | English | Compare |
Showing 1 to 6 of 6